2-FEA

Considered a Schedule I controlled substance as an analogue of amphetamine under Canadian drug scheduling laws.³

The current consolidated Opiumwet (effective 9 July 2026) contains Lijst IA stofgroep 1, covering chemical substances derivable from the 2-phenylethan-1-amine base structure that match the modular structure: the ring may be phenyl substituted by fluorine; the 2-amino-ethyl side chain permits an N-alkyl substituent up to C6 and alkyl substitution at the side-chain carbon atoms up to C10. The NIH PubChem identity record gives 2-fluoroethamphetamine as N-ethyl-1-(2-fluorophenyl)propan-2-amine, which has the matching ortho-fluorophenyl ring, N-ethyl group and alpha-methyl-substituted 2-aminoethyl chain. Article 2a prohibits importing/exporting, preparing, processing, selling, delivering, supplying, transporting, possessing and manufacturing a List IA-group substance or preparation. Article 2a(2) contains specific exceptions for defined medicines, pharmaceutical/veterinary manufacturers and wholesalers, registered drug precursors and List I/II means; no evidence establishes that ordinary 2-FEA is within an exception. Article 10b sets up to three months’ detention or a third-category fine for a non-intentional violation, up to six years’ imprisonment or a fifth-category fine for an intentional violation, and up to six months’ imprisonment or a third-category fine for an intentional small quantity for own use in the specified import/possession cases. Article 10c separately sets up to three years’ imprisonment or a fifth-category fine for intentional preparation or facilitation, with a non-punishability rule for facilitating import/export of a small quantity for own use. The prohibition described here applies only to 2-fluoroethamphetamine as N-ethyl-1-(2-fluorophenyl)propan-2-amine and does not extend to a different fluoroamphetamine, positional isomer, stereochemical composition or product unless its exact structure and any statutory exception support the same classification.

Controlled as a Class A substance under the amphetamine analogue clause of the Misuse of Drugs Act 1971.²⁰ Class A classification carries the most severe penalties under UK drug law.

Controlled under the Neue-psychoaktive-Stoffe-Gesetz (New Psychoactive Substances Act) since November 26, 2016.¹² Production and import with intent to market, administration to others, and trading are punishable offenses.¹³ Possession is prohibited but not subject to criminal penalties.

Classified as a Schedule 3 controlled substance due to its structural relationship to amphetamine under New Zealand's analogue provisions.¹⁸

Regulated as a controlled substance under Verzeichnis E point 130 as a defined derivative of α-methylphenethylamine.¹⁹ Exemptions exist for legitimate scientific or industrial applications.

ANSM's consolidated narcotics list is dated 26 June 2026 and expressly compiles the amended 1990 arrêté plus ANSM decisions; its Annex III names amphétamine and 4-fluoroamphétamine/4-FA but the full searchable list contains no 2-FEA, 2-fluoro-N-ethylamphetamine, 2-fluoroethamphetamine, ortho-fluoroethamphetamine or the PubChem IUPAC name. Annex IV's generic phenethylamine/alpha-methylphenethylamine clause requires substitution of the amine by at least one benzyl group (with the specified benzyl-ring substituent), which 2-FEA's N-ethyl group does not meet. The current ANSM psychotropics list (updated 3 July 2026) likewise contains no 2-FEA or its synonyms. MILDECA's current NPS guidance explains that substances not yet classified as stupéfiants escape the legislation on stupéfiants during the classification gap, while warning that 'legal highs' is misleading because medicines, product safety, consumer, customs, driving and other regimes may still apply. Accordingly, the current French controlled-substance schedules support unscheduled, not a blanket claim that every product or conduct involving 2-FEA is lawful. The drug-specific penalties below are conditional: current Service-Public guidance gives up to one year imprisonment and EUR 3,750 for illicit use of a classified stupéfiant, a EUR 500 fixed criminal fine (EUR 400 reduced, EUR 1,000 increased), and up to five years/EUR 75,000 for specified public-authority, public-service or transport roles; MILDECA summarizes trafficking penalties for classified stupéfiants, including up to 10 years and EUR 7,500,000 for illicit transport, detention, offer, cession, acquisition or employment, and higher penalties for production or organized activity. Those classified-stupéfiant penalties do not establish a 2-FEA penalty where 2-FEA is unscheduled.